Cell surface Ig superfamily proteins (IgSF) have been implicated in several aspects of neuron development and function. Here, we describe the function of a Caenorhabditis elegans IgSF protein, RIG-3. Mutants lacking RIG-3 have an exaggerated paralytic response to a cholinesterase inhibitor, aldicarb. Although RIG-3 is expressed in motor neurons, heightened drug responsiveness was caused by an aldicarb-induced increase in muscle ACR-16 acetylcholine receptor (AChR) abundance, and a corresponding potentiation of postsynaptic responses at neuromuscular junctions. Mutants lacking RIG-3 also had defects in the anteroposterior polarity of the ALM mechanosensory neurons. The effects of RIG-3 on synaptic transmission and ALM polarity were both mediated by changes in Wnt signaling, and in particular by inhibiting CAM-1, a Ror-type receptor tyrosine kinase that binds Wnt ligands. These results identify RIG-3 as a regulator of Wnt signaling, and suggest that RIG-3 has an antiplasticity function that prevents activity-induced changes in postsynaptic receptor fields.
INTRODUCTION
Cell surface IgSF proteins are implicated in diverse aspects of neuronal development, including cell and axon migration, target recognition, axon fasciculation, axon ensheathment by glia, synapse formation, and synapse function (Rougon and Hobert, 2003; Takeda et al., 2001; Walsh and Doherty, 1997) . Many IgSF proteins act as either homo-or heterophilic cell adhesion molecules (CAMs), e.g., NCAM (Yamada and Nelson, 2007) . Other IgSF proteins act as receptors for secreted ligands, or as auxiliary subunits of such receptors (Barrow and Trowsdale, 2008; Wang and Springer, 1998) . IgSF proteins comprise a large family of proteins (765 in humans, 142 in flies, 80 in worms) (Lander et al., 2001; Vogel et al., 2003) and mutations in IgSF genes are associated with several human neurological disorders (Fransen et al., 1997; Sun et al., 2003; Uyemura et al., 1996) .
Several CAMs induce synapse formation (Biederer et al., 2002; Kurusu et al., 2008; Linhoff et al., 2009 ). For example, neurexin and neuroligin induce differentiation of post-and presynaptic specializations, respectively (Nam and Chen, 2005; Scheiffele et al., 2000) . Some CAMs confer specificity for specific types of synapses. Neuroligin-2 induces formation of GABA synapses, whereas neuroligin-1 promotes formation of glutamatergic synapses (Chih et al., 2005; Graf et al., 2004) . Synaptic CAMs also play an important role in regulating synaptic transmission. Neurexin-neuroligin complexes recruit postsynaptic glutamate receptors, while also altering synaptic vesicle recycling presynaptically (Chubykin et al., 2007; Futai et al., 2007; Varoqueaux et al., 2006) . N-cadherin is required for homeostatic plasticity (Goda, 2002; Okuda et al., 2007) and integrins promote LTP (Chan et al., 2003) .
Many aspects of neuron and synapse development are regulated by both positive and negative factors. Axon and cell migrations are shaped by gradients of secreted attractants and repellents (Tessier-Lavigne, 1994) . Similarly, synapse formation is governed by both positive (e.g., neurexin-neuroligin) and negative factors (e.g., Wnt) (Klassen and Shen, 2007; Poon et al., 2008; Scheiffele, 2003) . Here we show that RIG-3, a cell surface IgSF molecule, acts as an antiplasticity molecule, preventing a form of synaptic potentiation, and that it does so by altering Wnt signaling.
RESULTS

Mutants Lacking RIG-3 Are Hypersensitive to Aldicarb
To identify new molecules involved in neuromuscular signaling, we used RNAi to screen for cell adhesion molecules whose absence alters the responsiveness of Caenorhabditis elegans to the acetylcholinesterase inhibitor aldicarb. Aldicarb treatment causes acute paralysis due to the accumulation of acetylcholine (ACh) in the synaptic cleft at the neuromuscular junction (NMJ). Gene inactivations that alter synaptic function can cause either resistance or hypersensitivity to aldicarb Sieburth et al., 2005; Vashlishan et al., 2008) . For this screen, we selected a collection of 216 putative cell adhesion molecules, based on the presence of protein domains found in CAMs (data not shown).
A gene identified in this screen was rig-3, which encodes a GPI-anchored protein containing two Ig domains and a divergent fibronectin type III (FNIII) domain ( Figure 1A ). RIG-3 has a pattern of protein domains that is similar to the Drosophila proteins Klingon and Wrapper, and to mammalian NCAMs (Cox et al., 2004; Yamagata et al., 2003) . RIG-3 was previously implicated in axon guidance in C. elegans; however rig-3 single mutants do not show guidance defects (Schwarz et al., 2009) .
Inactivation of rig-3 by RNAi caused significant hypersensitivity to aldicarb ( Figure 1B ) and a similar defect was observed in homozygous rig-3(ok2156) mutants ( Figure 1C ). The ok2156 mutation deletes 1.5 kb of the rig-3 gene, spanning exons 2-5 (including most of the Ig domains and part of the FNIII domain); consequently, ok2156 is likely to cause a severe loss of gene function (www.wormbase.org) ( Figure 1A ) (Schwarz et al., 2009) .
The rig-3 aldicarb hypersensitivity defect was rescued by transgenes driving RIG-3 expression in all neurons (utilizing the snb-1 Synaptobrevin promoter, data not shown) and in cholinergic neurons (utilizing the unc-17 VAChT promoter) ( Figure 1C ). By contrast, rig-3 transgenes expressed in GABA neurons, or in the intestine lacked rescuing activity ( Figure 1C ). None of these transgenes altered aldicarb responsiveness of wild-type animals (data not shown). These results suggest that RIG-3 functions in cholinergic neurons to regulate some aspect of neuromuscular function or development.
Prior work showed that rig-3 is expressed in neurons and in the intestine (www.wormbase.org) (Schwarz et al., 2009) . A construct containing the full rig-3 genomic region, with mCherry inserted just after the signal sequence ( Figure 1A ), was expressed in ventral cord motor neurons but not in body muscles ( Figure 2A and data not shown). To identify the rig-3 expressing motor neurons, we performed several double labeling experiments. The rig-3 construct was coexpressed with acr-2 (A, B, and AS neurons), unc-4 (VA and DA neurons), unc-129 (DA neurons), but not with ceh-12 (VB neurons) reporters, which are expressed in the indicated motor neuron classes (Figure 2 ; see Figure S2 available online; data not shown). These results suggest that RIG-3 is expressed in the VA and DA motor neurons (and possibly the AS neurons).
To determine the subcellular localization of the RIG-3 protein, we analyzed the expression of mCherry-tagged RIG-3. The mCherry::RIG-3 genomic construct rescued the rig-3 aldicarb defect ( Figure 1C ), demonstrating that this chimeric protein retained RIG-3 function. mCherry::RIG-3 was distributed in a punctate pattern in dorsal cord axons, and the RIG-3 puncta fluorescence was partially colocalized with the SV protein SNB-1, consistent with RIG-3 enrichment at presynaptic elements (Figure 2B ). RIG-3 fluorescence was also observed in coelomocytes ( Figure 2C ), which are phagocytic cells that internalize proteins secreted into the body cavity (Fares and Grant, 2002) . The coelomocyte fluorescence most likely corresponds to RIG-3 shed from neuronal membranes (perhaps due to hydrolysis of the GPI-anchor). Thus, RIG-3 may function as either a cell surface or a secreted protein. A control construct expressing cytoplasmic mCherry in cholinergic motor neurons did not produce coelomocyte fluorescence ( Figure 2D ).
We did several experiments to test the functional importance of membrane-tethered and secreted RIG-3. A RIG-3 construct lacking the C-terminal GPI-anchoring signal, RIG-3(DGPI), exhibited decreased axonal and increased coelomocyte fluorescence ( Figure S1 ), and failed to rescue the aldicarb hypersensitivity defect of rig-3 mutants ( Figure 1C) . Furthermore, RIG-3 expressed in GABA neurons (with the unc-25 promoter) did not rescue the aldicarb hypersensitivity seen in rig-3 mutants ( Figure 1C ), as would be predicted if secreted RIG-3 lacks rescuing activity. By contrast, a transgene expressing a constitutively membrane-anchored protein, RIG-3(TMD), in cholinergic neurons produced axonal fluorescence, lacked coelomocyte fluorescence, and partially rescued the aldicarb hypersensitivity defect ( Figure 1C ; Figure S1 ). These results indicate that the synaptic function of RIG-3 is primarily mediated by membraneassociated RIG-3 at presynaptic elements and not by secreted RIG-3.
Synapse Morphology Is Normal in rig-3 Mutants
The rig-3 aldicarb defect could arise from altered development of neurons or synapses. We did several experiments to address this possibility. The number of ventral cord neurons and their axon morphologies were unaltered in rig-3 mutants (data not shown), consistent with prior studies (Schwarz et al., 2009 ).
We also analyzed the morphology of neuromuscular junctions with several synaptic markers. We found no significant differences in the morphology, fluorescence intensity, or density of cholinergic and GABAergic NMJs in rig-3 mutants using GFP-tagged SNB-1 Synaptobrevin and SYD-2 a-liprin (an active zone protein) as markers (Figures S2C and S2D ; data not shown). Adhesion molecules often anchor the cortical actin cytoskeleton to the plasma membrane (Leshchyns'ka et al., 2003) . To analyze the actin cytoskeleton at synapses, we expressed two GFP-tagged actin-binding proteins in cholinergic neurons (GSNL-1 gelsolin and SNN-1 synapsin). GSNL-1 and SNN-1 fluorescence were unaltered in rig-3 mutants, indicating a relatively normal actin cytoskeleton (Figure S2E ; data not shown). These results indicate that rig-3 mutants do not have significant defects in synapse formation or maintenance.
Baseline Synaptic Transmission Is Normal in rig-3 Mutants We did several experiments to determine if the rig-3 aldicarb defect is caused by changes in baseline synaptic transmission.
To assay synaptic transmission, we recorded excitatory and inhibitory postsynaptic currents (EPSC and IPSC) from body muscles. The amplitude and rate of endogenous EPSCs and IPSCs were not altered in rig-3 mutants, indicating that baseline cholinergic and GABAergic transmission were both normal (Figure 3A ; Figure S3 ). The amplitude and total synaptic charge of EPSCs evoked by a depolarizing stimulus were also unaltered ( Figure 3B ). To assess changes in postsynaptic AChRs, we analyzed expression of ACR-16 receptors. ACR-16::GFP puncta fluorescence was slightly increased in rig-3 mutants compared to wild-type controls (15%, p < 0.01) ( Figure 4A) ; however, the amplitude of currents evoked by bath applied ACh were not altered in rig-3 mutants, suggesting that muscle sensitivity to ACh was normal ( Figure 3C ). Taken together, these results indicate that inactivation of RIG-3 does not significantly alter baseline synaptic transmission.
Aldicarb Induces Increased Muscle Sensitivity to ACh in rig-3 Mutants
We recently showed that ACh release at NMJs is enhanced after brief treatments with aldicarb (Hu et al., 2011) . Thus, the rig-3 aldicarb defect could result from an exaggeration of this aldicarb mediated presynaptic potentiation. To test this idea, we measured the effect of aldicarb treatment on EPSC rates. A 60 min aldicarb treatment caused identical increases in the EPSC rate of both wild-type and rig-3 mutants ( Figure 3A ). These results suggest that the rig-3 aldicarb hypersensitivity defect was not caused by increased ACh release. Several results suggest that rig-3 mutant muscles have increased responsiveness to ACh after aldicarb treatment. We used three assays to measure muscle ACh responses: the amplitudes of endogenous EPSCs, of stimulus evoked EPSCs, and of currents activated by exogenously applied ACh. Aldicarb treatment increased the amplitude of endogenous EPSCs recorded from rig-3 mutant muscles whereas those recorded from wild-type animals were unaltered ( Figure 3A ; Figures  S3B and S3C) . Aldicarb had no effect on the decay kinetics of endogenous EPSCs in rig-3 or in wild-type controls (Figure S3B) . The amplitude and total synaptic charge of evoked responses in aldicarb treated rig-3 mutants were both significantly greater than that observed in aldicarb treated wild-type controls ( Figure 3B ). Aldicarb treatment also significantly increased the amplitude of ACh-activated currents in rig-3 mutants whereas those recorded from wild-type animals were significantly reduced ( Figure 3C ). The rig-3 defects in endogenous EPSC, evoked EPSC, and ACh-activated currents were all rescued by a rig-3 transgene expressed in cholinergic neurons ( Figure 3 ; Figure S3C ). By contrast, aldicarb pretreatment had no effect on the amplitude of endogenous IPSCs recorded from either wild-type or rig-3 mutant muscles, suggesting that body muscle responses to GABA were unaltered ( Figure S3A ). Taken together, these results suggest that aldicarb enhances body muscle ACh responses in rig-3 mutants (but not in wild-type controls) and that this effect is specific for ACh responses. 
Aldicarb Increases the Synaptic Abundance of ACR-16 Receptors in rig-3 Mutants
Increased ACh responses could be caused by altered expression or activity of nicotinic AChRs. C. elegans body muscles express two classes of nicotinic AChRs, homomeric ACR-16 receptors and heteropentameric ab-type receptors that are sensitive to a synthetic agonist levamisole. Levamisole (Lev) receptors account for only 20% of the synaptic and ACh-activated currents in body muscles (Francis et al., 2005; Touroutine et al., 2005) . After aldicarb treatment, ACR-16::GFP puncta fluorescence was significantly increased in rig-3 mutants (35%, p < 0.001), while levels in wildtype animals were unaltered ( Figure 4A ). By contrast, aldicarb treatment had no effect on UNC-29::GFP Lev receptor fluorescence nor on UNC-49::GFP GABA A receptor fluorescence (consistent with the unaltered IPSC amplitudes) in both wild-type and rig-3 mutants ( Figure S4 ), indicating that this effect was specific for ACR-16 receptors. This increase in ACR-16 fluorescence was fully rescued by a transgene expressing RIG-3 in cholinergic neurons ( Figure 4A ). Collectively, these results demonstrate that inactivation of rig-3 reveals an aldicarb-induced potentiation of synaptic transmission, which may result from increased synaptic abundance of ACR-16 receptors.
The Effect of RIG-3 on ACR-16 Is Restricted to Adjacent Postsynaptic Targets Presynaptic RIG-3 could regulate postsynaptic receptors by either of two general mechanisms. RIG-3 could act in a spatially restricted manner, regulating ACR-16 levels in adjacent postsynaptic membranes. Alternatively, RIG-3 expressed in one neuron could regulate ACR-16 abundance at NMJs formed by neighboring neurons. To distinguish between these possibilities, we examined the effect of RIG-3 expression in the DA motor neurons. DA neurons have cell bodies in the ventral midline, they extend a dendritic process in the ventral cord (which receives synaptic input from interneurons), and an axonal process in the dorsal cord (which forms NMJs with dorsal body muscles) (Figure 4B) . mCherry-tagged RIG-3 expressed in DA neurons was targeted to puncta in dorsal cord axons whereas little RIG-3 fluorescence was observed in the DA ventral cord processes ( Figure 4B ), consistent with presynaptic targeting of . Transgenes expressing RIG-3 in DA neurons rescued the rig-3 ACR-16 fluorescence defect in the dorsal cord, but did not rescue the ACR-16 defect in the ventral cord ( Figures 4C  and 4D ) nor the rig-3 aldicarb paralysis defect ( Figure S4C ). These results suggest that the active form of RIG-3 is restricted to axons and that RIG-3 functions in a spatially restricted manner, regulating ACR-16 levels in adjacent postsynaptic membranes. ACR-16 Receptors Are Required for Aldicarb-Induced Potentiation of rig-3 Mutant Synapses Increased ACR-16 targeting to synapses could provide a mechanism to explain the aldicarbinduced enhancement of synaptic transmission in rig-3 mutants. Consistent with this idea, the aldicarb hypersensitivity, the increased EPSC amplitudes, and the increased ACh-activated current after aldicarb treatment were all eliminated in acr-16; rig-3 double mutants ( Figure 5 ). The residual ACh-activated current in acr-16 mutants are a direct measure of Lev receptor function; consequently, this double mutant analysis demonstrates that ACR-16 receptors are absolutely required for the synaptic effects of RIG-3, and changes in Lev receptor mediated currents are not observed in rig-3 mutants. Overexpression of ACR-16 in wild-type body muscles also produced hypersensitivity to aldicarb ( Figure 5A ), suggesting that increased ACR-16 levels are sufficient to cause this defect. However, increased expression of the acr-16 gene is unlikely to explain the rig-3 mutant phenotype because quantitative PCR did not detect significant changes in acr-16 mRNA levels after aldicarb treatment: acr-16 mRNA levels after aldicarb treatment (normalized to untreated controls) rig-3 = 0.80 ± 0.09, wild-type = 0.77 ± 0.13. These results suggest that aldicarb regulates ACR-16 in a posttranscriptional manner in rig-3 mutants, thereby enhancing synaptic transmission. These results also indicate that changes in ACR-16 can account for all of the rig-3 synaptic defects.
ACR-16 Mobility in the Nerve Cord Is Increased in rig-3 Mutants
The receptors present at a synapse are provided by the dynamic exchange between a mobile pool of receptors, and receptors bound at postsynaptic elements (Opazo and Choquet, 2011) . To determine how RIG-3 alters this equilibrium, we analyzed fluorescence recovery after photobleaching (FRAP) of ACR-16::GFP puncta in the dorsal nerve cord (Figure 6 ). The ACR-16 FRAP observed in untreated wild-type controls and rig-3 mutants were not significantly different. After aldicarb treatment, FRAP was significantly increased in rig-3 mutants, but was unaltered in wild-type controls. By contrast FRAP of UNC-49::GFP (GABA A receptor) was unaltered by aldicarb treatment in both wild-type and rig-3 mutants ( Figure S5 ). These experiments indicate that aldicarb treatment significantly increased the population of mobile ACR-16 receptors in rig-3 mutants, but not in wild-type controls. These results support the idea that RIG-3 restricts the exchange between synaptic and mobile ACR-16 receptors, and that it does so by controlling the number of mobile receptors available for synaptic recruitment.
CAM-1 Is Required for RIG-3 Regulation of ACR-16
A prior study showed that CAM-1, a Ror-type receptor tyrosine kinase (RTK), promotes ACR-16 delivery to NMJs, but does not regulate Lev receptor levels (Francis et al., 2005) . Consistent with this study, we observed modestly reduced synaptic CAM-1 and RIG-3 have opposite effects on synaptic ACR-16 levels and both selectively regulate ACR-16, having little effect on Lev receptors (Francis et al., 2005) . Prompted by these results, we tested the idea that the effects of RIG-3 on ACR-16 are mediated by changes in CAM-1 activity. Consistent with this idea, the aldicarb hypersensitivity, the increased endogenous EPSC amplitudes, and the increased ACR-16::GFP levels after aldicarb treatment were all eliminated in cam-1; rig-3 double mutants (Figures 7A-7C ). To determine if RIG-3 regulates CAM-1 levels, we analyzed GFP-tagged CAM-1 fluorescence in body muscles. Aldicarb treatment significantly increased CAM-1 puncta fluorescence in the nerve cord of rig-3 mutants, but had no effect on CAM-1 levels in wild-type controls ( Figure 7D ). Taken together, these results suggest that RIG-3 negatively regulates CAM-1 levels at NMJs, and that increased CAM-1 activity is required for the effects of RIG-3 on ACR-16.
Several prior studies showed that CAM-1 binds secreted Wnt ligands and functions as a Wnt receptor or as an antagonist inhibiting signaling by other Wnt receptors (Green et al., 2008) . Prompted by these results, we wondered if the effects of RIG-3 on synaptic transmission could result from changes in Wnt signaling at the NMJ. Consistent with this idea, we found that a mig-14 Wntless mutation, which reduces Wnt secretion ( (i.e., non-Wnt) signaling pathways; consequently, these results strongly support the idea the effects of RIG-3 on the NMJ are mediated by changes in Wnt signaling.
RIG-3 Alters Wnt Regulation of ALM Polarity
The effects of RIG-3 on CAM-1 at NMJs suggest that RIG-3 might also regulate Wnt signaling in other tissues. To test this idea, we analyzed the anteroposterior polarity of the ALM mechanosensory neurons. Several prior studies showed that ALM polarity is regulated by Wnt signaling (Hilliard and Bargmann, 2006; Prasad and Clark, 2006) . The mCherry-tagged rig-3 genomic construct was expressed in ALM neurons ( Figure 8A ), suggesting that RIG-3 could play a role in Wnt mediated control of ALM polarity. In wild-type animals, ALM neurons have a single anteriorly directed process ( Figures 8B and 8C ). In mutants with decreased Wnt signaling, ALM neurons exhibit either of two defects, with some neurons having both an anterior and a posterior process (bipolar ALMs) while others have a single posteriorly directed process (reversed ALMs) ( Figures 8B and 8C ) (Fleming et al., 2010; Prasad and Clark, 2006) . The prevalence of bipolar and reversed ALM neurons differs among Wnt mutants. These differences in ALM defects likely result from the fact that C. elegans has five Wnt ligands, which have distinct effects on ALM polarity. For example, two prior studies showed that the effects of two Wnts (CWN-1 and EGL-20) on ALM polarity are antagonized by a third Wnt (LIN-44) (Fleming et al., 2010; Prasad and Clark, 2006) . Thus, the precise ALM phenotype observed is determined by how each mutation alters signaling by the different Wnt ligands.
To further investigate if RIG-3 plays a role in Wnt signaling, we analyzed the effect RIG-3 inactivation on ALM polarity in several genetic backgrounds. Although ALM polarity was unaltered in rig-3 single mutants, the rig-3 mutation significantly altered ALM polarity defects caused by other Wnt pathway mutations in double and triple mutants. Inactivating RIG-3 in cwn-1; egl-20 double mutants decreased the severity of ALM polarity defects: ALM reversals were significantly reduced in cwn-1; egl-20; rig-3 triple mutants (p < 0.01, Fishers exact test), while the number of bipolar ALMs was unaffected (p = 0.21, Fishers exact test). Inactivating RIG-3 in mig-14 Wntless mutants decreased ALM reversals and increased bipolar ALMs ( Figures  8B and 8C) . The different outcome in mig-14 mutants likely results from the fact that MIG-14 is required for secretion of all Wnt ligands. By contrast, the rig-3 mutation had no effect on ALM polarity in two strains lacking CAM-1, i.e., cam-1; rig-3 double mutants and cam-1 mig-14; rig-3 triple mutants (Figure 8C) . These results lead to three conclusions. First, RIG-3 plays an important role in Wnt regulation of ALM polarity. Second, CAM-1 is absolutely required for the effects of RIG-3 on ALM polarity. Third, the effects of RIG-3 on ALM polarity and on ACR-16 levels at the NMJ can both be explained by changes in Wnt signaling.
DISCUSSION
Our results lead to six primary conclusions. First, RIG-3 acts in motor neurons to prevent a form of postsynaptic plasticity that is induced by aldicarb treatment. Second, inactivating RIG-3 has no effect on baseline synaptic transmission, suggesting that the function of RIG-3 is required only during aldicarbinduced plasticity. Third, the synaptic potentiation observed in rig-3 mutants is mediated by aldicarb-induced accumulation of postsynaptic ACR-16 nAChR receptors. Fourth, RIG-3 decreases the number of mobile ACR-16 receptors available for recruitment into postsynaptic receptor fields. Fifth, inactivating RIG-3 also alters the polarity of ALM neurons. And sixth, the effects of RIG-3 on cholinergic transmission and on ALM polarity are both mediated by changes in Wnt signaling, and in particular by inhibiting the activity of a Wnt-binding protein (CAM-1). Below, we discuss the significance of these findings.
RIG-3 Regulates Wnt Signaling
Several results suggest that RIG-3 inhibits the function of CAM-1. First, aldicarb treatment increased CAM-1 levels at NMJs in rig-3 mutants, but not in wild-type controls. Second, a cam-1 null mutation eliminated the effects of RIG-3 on aldicarb responses, EPSCs, ACR-16 levels, and ALM polarity. This double mutant analysis is particularly informative. The cam-1 mutation completely occludes the effects of RIG-3 on ACR-16 trafficking, despite the fact that ACR-16 levels are only modestly reduced in cam-1 mutants (80% wild-type levels). These results provide strong genetic evidence that CAM-1 acts downstream of RIG-3. Thus, both double mutant analysis and imaging data support the idea that RIG-3 regulates ACR-16 and ALM polarity through changes in CAM-1 activity. The effects of RIG-3 on CAM-1 levels could occur through a variety of mechanisms. RIG-3 and CAM-1 both contain Ig domains, which could mediate direct binding interactions between these proteins. Alternatively, RIG-3 could inhibit Wnt secretion or Wnt binding to CAM-1 or other Wnt receptors.
CAM-1 can function as a receptor mediating the effects of Wnt ligands or as an antagonist inhibiting Wnt binding to other Wnt receptors (Green et al., 2008) . Despite this ambiguity, all of the known effects of CAM-1 on development are mediated by changes in Wnt signaling (Green et al., 2008) . Thus, absolute requirement of RIG-3 for CAM-1 suggests that the effects of RIG-3 on synaptic transmission and on ALM polarity are both mediated by changes in Wnt signaling.
RIG-3 inhibition of CAM-1 could potentially promote or inhibit Wnt signaling, depending on whether CAM-1 functions as a receptor or an antagonist. Consequently, to assess how RIG-3 alters Wnt signaling, we compared the effect of rig-3 mutations to those caused by mutations inactivating Wnt ligands or decreasing Wnt secretion. At the NMJ, a mig-14 Wntless mutation and a rig-3 mutation had opposite effects on aldicarbinduced paralysis and the effect of RIG-3 on aldicarb-responsiveness was eliminated in mig-14; rig-3 double mutants. These results suggest that RIG-3 regulates aldicarb responses by inhibiting Wnt signaling at the NMJ.
For ALM polarity, the results are more complicated. Prior studies showed that four Wnt ligands play a role in dictating ALM polarity but that distinct ALM defects (i.e., bipolar versus reversed ALM neurons) are observed when different combinations of Wnts are inactivated (Fleming et al., 2010; Prasad and Clark, 2006) . Two results suggest that a global reduction in Wnt signaling primarily leads to reversed ALM neurons: quintuple mutants containing mutations in all five Wnt ligands (55% reversed, 5% bipolar) (Fleming et al., 2010) and mig-14 mutants (which reduce secretion of all Wnt ligands) (69% reversed, 12% bipolar) (Figure 8 ). These data indicate that the different ALM phenotypes observed in Wnt mutants are analogous to an allelic series whereby more extreme Wnt defects cause primarily ALM reversals while less severe defects cause fewer reversals and increased bipolar ALMs. Inactivating RIG-3 in cwn-1; egl-20 double mutants significantly decreased reversed ALMs and had no effect on bipolar ALMs, indicating that RIG-3 and these two Wnt ligands have opposite effects on ALM polarity. Inactivating RIG-3 in mig-14 mutants also resulted in a less severe phenotype (with decreased ALM reversals and increased bipolar ALMs). In both experiments, rig-3 mutations and mutations inactivating Wnt signaling had opposite effects on ALM polarity. Thus, analysis of the effects of RIG-3 on the NMJ and on ALM polarity both support the idea that RIG-3 normally inhibits Wnt signaling. These results do not exclude the possibility that RIG-3 promotes Wnt signaling in other contexts. In particular, in cases where CAM-1 functions as a Wnt antagonist, RIG-3 inhibition of CAM-1 could enhance Wnt signaling.
Wnts have been implicated in many aspects of neuronal development, including axon guidance, cell migrations, and synapse formation (Budnik and Salinas, 2011) . Although Wnts are often involved in regulating development, several results suggest that RIG-3's and CAM-1's effects on ACR-16 trafficking are not mediated by changes in synapse development. Inactivation of RIG-3 had no effect on synapse morphology nor on baseline synaptic transmission at adult cholinergic and GABAergic NMJs, suggesting that development of these synapses had not been altered. Instead, a rig-3 synaptic defect was apparent only after treating adult animals with aldicarb, implying the RIG-3 is required for aldicarb-induced plasticity. Postsynaptic responses at these cholinergic NMJs are mediated two classes of nicotinic receptors (i.e., ACR-16 and Lev receptors). In rig-3 mutants, aldicarb treatment increased ACR-16 levels and ACR-16-mediated currents, but had no effect on UNC-29 Lev receptor levels nor on Lev receptor-mediated currents. These results argue strongly against a developmental basis for the rig-3 synaptic defect because disruptions of synapse or muscle development would alter both postsynaptic receptors equally, and would not be contingent on aldicarb treatment. For these reasons, we propose that RIG-3 regulates Wnt signals involved in both neural development (ALM polarity) and synaptic plasticity (ACR-16 trafficking).
Wnts are implicated in several other examples of synaptic plasticity. For example, activity evokes Wnt secretion in both Drosophila and in rodent hippocampal neurons, mediating activity dependent plasticity in both cases (Ataman et al., 2008; Chen et al., 2006) .
Implications for Wnt Signaling
Several other Wnt antagonists have been described (Kawano and Kypta, 2003) . For example, secreted frizzled-related proteins (SFRPs) bind Wnt ligands, inhibiting their signaling. Secreted Dickkopf proteins bind to low density lipoprotein receptor related proteins (LRPs), which are accessory subunits for Frizzled receptors, thereby inhibiting Wnt signaling. We show that RIG-3 inhibits CAM-1, a receptor mediating noncanonical Wnt signaling. These results suggest that different inhibitors are utilized to inhibit canonical and noncanonical Wnt pathways. Prior studies focused primarily on the developmental effects of Wnt antagonists. Our results suggest that RIG-3 (and potentially other Wnt antagonists) could also regulate activityinduced synaptic plasticity in mature animals. Like Wnts, several other secreted morphogens have also been implicated in regulating synaptic function, including IGFs, BMPs, and EGF related ligands (Chiu and Cline, 2010; Keshishian and Kim, 2004; Mei and Xiong, 2008) . Antagonists have been identified for each of these morphogens (Ferná ndez-Gamba et al., 2009; Ghiglione et al., 1999; Schweitzer et al., 1995; Smith, 1999) . It will be interesting to see if other morphogen antagonists also act as antiplasticity molecules.
RIG-3 Constrains Postsynaptic Plasticity
C. elegans has been extensively utilized as a model to study synapse development and function. One limitation of this model has been the absence of a paradigm for studying synaptic plasticity. Our analysis of rig-3 mutants identified a form of postsynaptic potentiation whereby a brief treatment with aldicarb induces an increased abundance of postsynaptic ACR-16 receptors and a corresponding increase in postsynaptic currents. By contrast, none of these effects were observed after aldicarb treatment of wild-type controls. Collectively, these results demonstrate that inactivation of RIG-3 reveals a form of plasticity whereby the activity-dependent delivery of ACR-16 receptors to synapses is enhanced.
Analysis of vertebrate synapses has shown that receptors mediating postsynaptic responses are supplied by a mobile pool of receptors in the plasma membrane that are retained at synapses by diffusional trapping (Opazo and Choquet, 2011) . We propose that RIG-3 regulates synaptic delivery of ACR-16 by an analogous mechanism. C. elegans NMJs are formed in the dorsal and ventral nerve cords by en passant contacts between motor neuron axons and processes extending from body muscles (which are termed muscle arms). In rig-3 mutants, aldicarb treatment increases the mobile fraction of GFP-tagged ACR-16 receptors in the nerve cord. These mobile ACR-16 receptors are likely in the plasma membrane of muscle arms, as receptors residing in intracellular organelles are typically immobile (Tardin et al., 2003) . An increased number of mobile ACR-16 receptors available for diffusional trapping would be expected to cause a corresponding increase in synaptic ACR-16 receptors (Opazo and Choquet, 2011) .
Although RIG-3 regulates postsynaptic receptor trafficking, RIG-3 functions in the presynaptic membrane. RIG-3 is expressed in cholinergic motor neurons, is enriched near presynaptic elements, and the active form of RIG-3 is tethered to the presynaptic plasma membrane. Thus, the effects of RIG-3 on ACR-16 levels are triggered from a presynaptic location. Trans-synaptic regulation of ACR-16 levels by RIG-3 could occur by a variety of mechanisms. Presynaptic RIG-3 could antagonize signaling by secreted Wnt molecules. In this scenario, one might expect that RIG-3 expressed in one motor neuron would regulate ACR-16 levels at synapses formed by neighboring neurons. Contrary to this idea, we found that the effects of RIG-3 on ACR-16 are spatially restricted to nearby postsynaptic elements, and possibly to direct postsynaptic targets. Other potential mechanisms for trans-synaptic regulation of ACR-16 levels include direct binding of RIG-3 to postsynaptic CAM-1 receptors, or local regulation of Wnt binding to CAM-1 expressed in postsynaptic partners. Further experiments will be required to determine the precise mechanisms by which RIG-3 and CAM-1 regulate ACR-16 trafficking.
RIG-3 regulated plasticity is similar in some respects to LTP at hippocampal synapses in rodents. In both synapses, postsynaptic currents are a composite of receptors with fast (ACR-16 and AMPA) and slow (Lev receptors and NMDA) kinetics, and potentiation is mediated by increased delivery of fast receptors. In this context, it is intriguing that some forms of LTP are disrupted by interfering with Wnt signaling (Chen et al., 2006) .
Aldicarb treatment also induces a form of presynaptic potentiation (Hu et al., 2011) . This presynaptic effect is mediated by aldicarb-induced secretion of an endogenous neuropeptide (NLP-12), which enhances ACh release at NMJs. Thus, the C. elegans body wall cholinergic NMJ exhibits pre-and postsynaptic forms of plasticity, both of which are induced by aldicarb treatment, but which are mediated by distinct signaling pathways. It will be interesting to determine if these two forms of aldicarb induced plasticity are coordinately regulated.
Implications for Circuit Function
Several adhesion molecules are known to promote recruitment of postsynaptic receptors. In particular, Neuroligin-1 promotes recruitment of glutamate receptors to synapses, whereas Neuroligin-2 promotes recruitment of GABA receptors (Chih et al., 2005; Graf et al., 2004) . Several other families of cell surface molecules also promote synaptic targeting of receptors, including auxiliary subunits (e.g., TARPs) and CUB domain containing proteins (e.g., SOL-1 and LEV-10) (Chen et al., 2000; Gally et al., 2004; Zheng et al., 2004) . Our results suggest that cell surface IgSF proteins (like RIG-3) can also stabilize synaptic signaling, by preventing plastic changes in postsynaptic receptor fields. Thus, we propose that the dynamic behavior of postsynaptic receptors is regulated by both positive and negative factors.
Antiplasticity molecules like RIG-3 could play important roles in circuit development or function. In particular, we envisage two potential functions for antiplasticity molecules. During development, morphogens typically induce bistable signals, producing switch-like changes in cellular fates. This property of morphogen signaling could be particularly useful in the context of developing circuits. During development, many circuits undergo activitydependent synaptic refinement, where plasticity in each circuit is restricted to specific times during development, often referred to as critical periods (Hensch, 2004) . Thus, these forms of critical period plasticity occur in a switch-like manner, opening and closing during specific developmental time windows. We speculate that morphogens and their antagonists may provide a biochemical mechanism for spatial and temporal patterning of synaptic plasticity during development.
Antiplasticity molecules could also stabilize circuit function. It has long been proposed that mechanisms must exist that oppose correlation based rules for activity-dependent plasticity (e.g., LTP and LTD) (Miller, 1996) . These correlation based plasticity rules are thought to confer instability on circuits because repeated potentiation or depression would systematically shift all synapses to higher or lower activities. Homeostatic plasticity (or metaplasticity) has been proposed as a potential solution to this problem (Pratt et al., 2003) . We propose that antiplasticity molecules may also perform this stabilizing function. Inappropriate changes in circuit activity could be prevented by expression of molecules such as RIG-3, whose function is to prevent expression of plasticity. Conversely, mutations in antiplasticity molecules would perturb circuit activity, and may contribute to cognitive and behavioral disorders.
EXPERIMENTAL PROCEDURES Strains
Strains were maintained as described previously at 20 C (Brenner, 1974) .
OP50 Escherichia coli were used for feeding. The wild-type reference strain was N2 Bristol. Descriptions of allele lesions can be found at www. wormbase.org. The mutant strains used were: eri-1(mg366), lin-15B(n744), rig-3(ok2156), acr-16(ok789), cam-1(ak37), mig-14(ga62), cwn-1(ok546), and egl-20(n585) .
RNAi Feeding Assay
RNAi assays were performed in the eri-1; lin-15b background . RNAi clones utilized were previously described (Kamath and Ahringer, 2003; . Acute aldicarb assays were performed in triplicate on young adult worms by an experimenter unaware of the identity of the RNAi clone utilized, all as described (Lackner et al., 1999) . Aldicarb (Sigma and Roche) concentration was 1 mM.
Fluorescence Microscopy and Quantitative Analysis
All quantitative imaging was done using a Olympus PlanAPO 1003 1.4 NA objective and an ORCA100 CCD camera (Hamamatsu). Worms were immobilized with 30 mg/ml BDM (Sigma). Imaging was done in either untreated animals or after a 60 min exposure to 1 mM aldicarb. Line scans of dorsal cord fluorescence were analyzed in Igor Pro (WaveMetrics) using customwritten software (Burbea et al., 2002; Dittman and Kaplan, 2006) . For coelomocyte imaging, the posterior coelomocyte was imaged in larval stage 4 (L4) and early adult worms (Sieburth et al., 2007) . All p values indicated were based on Student's t tests. ALM polarity was visualized with the integrated transgene zdIs5 , in animals immobilized with 1% sodium azide, using a Zeiss Axioskop2 microscope. The zdIs5 transgene is expressed in six mechanosensory neurons, ALMs, PLMs, AVM, and PVM (Pan et al., 2008) . For ALM, the bipolar phenotype was defined as a normal anterior process and a posterior process that is longer than five ALM cell diameters in length. p values were determined by the Fisher exact test.
FRAP experiments were performed using the Olympus FV1000 confocal microscope. Image stacks were captured, and maximum intensity projections were obtained using Metamorph 7.1 software (Universal Imaging). For FRAP experiments, the worms were immobilized in 10% agarose containing 0.5 ml of 0.1 mm polystyrene microspheres (Polysciences). Animals were imaged at 5 and 10 min intervals until 55 or 65 min after photobleaching. To control for motion artifacts, we measured fluorescence of neighboring unbleached ACR-16 puncta. We excluded any experiments where the fluorescence of neighboring puncta changed by >10% over the course of the experiment.
Electrophysiology
Electrophysiology was done on dissected adults as previously described (Richmond and Jorgensen, 1999) . All recording conditions were as described previously (Sieburth et al., 2007) . Aldicarb treatment refers to 60 min in 1 mM aldicarb. For comparing average electrophysiological values, statistical significance was determined using the Mann-Whitney test or Student's t test. For cumulative probability distributions, the Kolmogorov-Smirnov test was used to determine statistical significance.
RIG-3 Constructs and Transgenes
Transgenic strains were generated by microinjection using several coinjection markers: KP#1338 (pttx-3::GFP), KP#1480 (pmyo-2::NLS-mCherry), or KP#1106 (pmyo-2::NLS-GFP) (Mello et al., 1991) . Integrated transgenes containing pmyo-3::ACR-16::GFP (nuIs299) and the pmyo-3::CAM-1::GFP (nuIs465) were generated by UV mutagenesis. All of these constructs were derivatives of pPD49.26 or pPD95.75 (Addgene).
Five RIG-3 constructs rescued rig-3(ok2156) mutants: KP#5918 (psnb-1::RIG-3), KP#5914 (punc-17::RIG-3), KP#6005 (punc-17::mCherry::RIG-3), KP#6292 (punc-17::mCherry::RIG-3TMD), and KP#6298 (prig-3::mCherry:: RIG-3). Three RIG-3 constructs did not rescue rig-3(ok2156) mutants: KP #5915 (punc-25::RIG-3), KP#6012 (pvha-6::RIG-3), and KP#6305 (punc-17::mCherry::RIG-3DGPI). The punc-129::mCherry::RIG-3 expresses RIG-3 in DA neurons, and was used to assess rescue of ACR-16 defects in the dorsal versus ventral cords (KP#6008). All rescue constructs contained the RIG-3 cDNA, with mCherry inserted between the amino acids 42 and 43. The genomic mCherry::RIG-3 line was made using a 11kb RIG-3 genomic fragment with mCherry inserted between amino acids 42 and 43. RIG-3(DGPI) contains a deletion of the carboxy-terminal 23 amino acids. In RIG-3(TMD), the carboxy-terminal 23 residues or RIG-3 were replaced by transmembrane and cytoplasmic domains derived from NLG-1. Several transgenes containing GFP-tagged synaptic proteins were previously described: nuIs321 (punc-17::mCherry), nuEx379 (pacr-2::GFP), nuIs152 (punc-129::GFP::SNB-1), nuIs159 (punc-129::SYD-2::YFP), nuIs169 (punc-129::GSNL-1::YFP) (Sieburth et al., 2005 (Sieburth et al., , 2007 , zdIs5 (pmec-4::GFP) (Pan et al., 2008) , akIs38 (UNC-29::GFP), (Francis et al., 2005) and nuIs283 (pmyo-3::UNC-49::GFP) (J. Bai and J.M.K., unpublished data).
Quantitative PCR Experiments
For real-time PCR experiments, late L4 and early adult worms were transferred to mock treatment plates or plates containing 1 mM aldicarb for 1 hr after which the RNA from these animals was harvested and quantitative PCR performed as detailed in Simon et al. (2008) .
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